Acquire the license to the best health content in the world
Contact Us

Lymphocytosis Patients at Risk of Leukemia

Small but significant number will go on to develop lymphocytic leukemia

WEDNESDAY, Aug. 6 (HealthDay News) -- Chronic lymphocytic leukemia-phenotype cells are found in patients with lymphocytosis and in the general population, and a clinically significant number of them will go on to develop lymphocytic leukemia, according to a report published in the Aug. 7 issue of the New England Journal of Medicine.

Andy C. Rawstron, Ph.D., of Leeds Teaching Hospital in Leeds, U.K., and colleagues conducted a study of 1,520 subjects aged 62 to 80 years with normal blood count and 2,228 lymphocytosis patients. They looked for the presence of monoclonal B-cell lymphocytosis (MBL), and 185 subjects with chronic lymphocytic leukemia-phenotype MBL were followed up for a median of 6.7 years.

Among patients with normal blood count, 5.1 percent had monoclonal chronic lymphocytic leukemia-phenotype B cells, while the cells were detected in 13.9 percent of the subjects with lymphocytosis, the researchers report. Of the 185 patients who were followed-up, 51 (28 percent) went on to develop progressive lymphocytosis, 28 (15 percent) developed chronic lymphocytic leukemia and 13 (7 percent ) required chemotherapy, the report indicates. Although 62 patients (34 percent) died during follow-up, chronic lymphocytic leukemia was the cause of death in only four cases.

"The majority of deaths in persons with chronic lymphocytic leukemia-phenotype MBL are due to unrelated causes, but progressive chronic lymphocytic leukemia requiring chemotherapy will develop in a clinically significant proportion of subjects presenting with lymphocytosis," the authors write.

An author of the study reports a financial relationship with the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)
Editorial

Physician's Briefing